Medtronic's Micra AV Receives the US FDA's Approval as the World's Smallest Pacemaker to Treat AV Block
Shots:
- The approval is based on MARVEL 2 study evaluating the ability of the Micra’s internal sensor- monitoring atrial contractions and enable coordinated pacing between the atrium and ventricle thus providing AV synchrony pacing therapy to patients with AV block
- The MARVEL 2 study demonstrated a greater percentage of complete heart block patients with normal sinus rhythm having >70% AV synchrony during algorithm-mediated AV synchronous pacing than VVI pacing- showed no pauses/ episodes of pacing-induced tachycardia
- Medtronic’s Micra AV is the first and only FDA-approved leadless pacemaker- has shown 63% reduction in major complication and does not require leads or a surgical "pocket" under the skin
Click here to read full press release/ article | Ref: GlobeNewswire | Image: Medtronic
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com